Closing soon

Q301-- Molecular Thyroid Testing RFP

Description: A molecular assay which analyzes thyroid fine needle aspiration specimens from patients who have had a previous diagnosis of “atypical cells of undetermined significance” (Bethesda III) or “follicular neoplasm” (Bethesda IV).

Released
Aug 26, 2026
Closes
Sep 10, 2026(9 days left)

Files

Original attachments and procurement documents tied to this bid.

Federal RFP files are for Starbridge customers only.

You can request RFP files from all other buyer types for free on this site.

See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.
See your top 10 accounts